Sangamo Therapeutics Inc (NASDAQ:SGMO)

3.41
Delayed Data
As of Jan 30
 -0.175 / -4.89%
Today’s Change
2.72
Today|||52-Week Range
6.42
+8.44%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Biogen Inc
Sale8/29/2022400,000$5.33$2.1M-35.24%
Biogen Inc
Sale8/30/2022100,000$5.27$527.0K-36.21%
Macrae Alexander D
Sale2/25/202249,890$5.90$294.4K-42.37%
Ramelmeier R Andrew /sangamo/
EVP-Technical Operations
Sale2/25/202212,388$5.90$73.1K-42.37%
Mcclung Mark D
Chief Operating Officer & EVP
Sale6/25/202211,525$4.31$49.7K-20.37%
Fontenot Jason D
Senior Vice President & Chief Scientific Officer
Sale2/25/20226,248$5.90$36.9K-42.37%
Mcclung Mark D
Chief Operating Officer & EVP
Sale2/25/20224,610$5.90$27.2K-42.37%
Markels John H
Director
Buy6/03/20226,784$3.69$25.0K-8.60%
Durabaibu Prathyusha
Vice President-Finance
Sale2/25/20223,474$5.90$20.5K-42.37%
Willoughby Scott B
General Counsel & Senior Vice President
Sale4/24/20223,976$4.70$18.7K-29.61%
Page of 4